Andean Precious Metals Corp. (CVE:APM - Free Report) - Research analysts at Desjardins issued their FY2024 earnings estimates for Andean Precious Metals in a research note issued to investors on Monday, September 2nd. Desjardins analyst J. Sclodnick forecasts that the company will earn $0.20 per share for the year. Desjardins currently has a "Buy" rating and a $1.70 target price on the stock. Desjardins also issued estimates for Andean Precious Metals' FY2025 earnings at $0.38 EPS.
Andean Precious Metals Price Performance
Shares of CVE:APM remained flat at C$1.00 during midday trading on Thursday. The company had a trading volume of 102,801 shares, compared to its average volume of 164,861. Andean Precious Metals has a twelve month low of C$0.53 and a twelve month high of C$1.11. The stock has a market capitalization of C$149.36 million, a price-to-earnings ratio of 2.63 and a beta of 1.14. The stock has a fifty day moving average of C$1.02.
About Andean Precious Metals
(
Get Free Report)
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Read More
Before you consider Andean Precious Metals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andean Precious Metals wasn't on the list.
While Andean Precious Metals currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
